If such a reaction occurs, therapy with Atrovent Nasal Spray 0.03% should be stopped at once and alternative treatment should be considered. Exposure to temperatures above 120°F may cause bursting. Mechanism of Action. Each actuation delivers 17 mcg ipratropium The bronchodilatory efficacy and comparability of Atrovent HFA vs ATROVENT CFC were also studied in a one-year open-label safety and efficacy study in 456 COPD patients. ALL RIGHTS RESERVED, Atrovent® If used regularly as recommended, no further priming is required. Advise patients to consult their physician immediately if any of these symptoms develop while using Atrovent HFA Inhalation Aerosol. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Because lipid-insoluble quaternary cations pass into breast milk, caution should be exercised when Atrovent Nasal Spray 0.03% is administered to a nursing mother. Ipratropium bromide inhalation aerosol is contraindicated in patients with a history of hypersensitivity to soya lecithin or related food products such as soybean and peanut. bromide from the mouthpiece. Fertility of male or female rats at oral doses up to 50 mg/kg (approximately 1,600 times the maximum recommended daily intranasal dose in adults on a mg/m2 basis) was unaffected by ipratropium bromide administration. Medically reviewed by Drugs.com. In the one open-label controlled study in 456 COPD patients, the overall incidence of adverse events was also similar between Atrovent HFA and ATROVENT CFC formulations. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. Important information about using Atrovent HFA. Mechanism of Action Ipratropium bromide is an anticholinergic (parasympatholytic) agent which, based on animal studies, appears to inhibit vagally mediated reflexes by antagonizing the action of … Albuterol and ipratropium work by different mechanisms, but both cause the muscles of the airways to relax. The 200 inhalation unit has a net weight of 12.9 grams. Cough, rhinitis, and upper respiratory infection occurred in greater than or equal to 3% of patients in either ipratropium treatment group but not greater than placebo in the 12-week study. (ipratropium bromide) Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Ipratropium bromide is a quaternary amine that minimally crosses the n… Acute overdosage by intranasal administration is unlikely since ipratropium bromide is not well absorbed systemically after intranasal or oral administration. Two-year oral carcinogenicity studies in rats and mice have revealed no carcinogenic activity at doses up to 6 mg/kg. Following a 2 mg intravenous infusion over 15 minutes to the same 10 male volunteers, plasma ipratropium concentrations of 22-45 ng/mL were observed (>100 times the concentrations observed following intranasal administration). The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for Atrovent HFA and any potential adverse effects on the breastfed child from Atrovent HFA or from the underlying maternal condition. 430.4. Nasal Spray 0.03%. The inhaler comes with a dose indicator you can see through a small window on the plastic mouthpiece (see Figure 1). These adverse events were mild or moderate in nature, none was considered serious, none resulted in hospitalization and most resolved spontaneously or following a dose reduction. Learn atrovent with free interactive flashcards. Advise patients that Atrovent HFA is a bronchodilator for the maintenance treatment of bronchospasm associated with COPD and is not indicated for the initial treatment of acute episodes of bronchospasm where rescue therapy is required for rapid response. As you use the inhaler, the dose indicator will typically rotate during every 5 to 7 actuations (sprays) towards the next decreasing number (see Figure 2). These doses correspond, in each species, respectively, to approximately 160, 32,000, and 8,000 times the maximum recommended daily intranasal dose (MRDID) in adults on a mg/m2 basis. However, because Atrovent or ipratropium is considered as an anticholinergic drug (the first type of bronchodilator) while albuterol is known as s sympathomimetic beta agonist (targets the beta receptors) they have different specific mechanisms of drug action… Store tightly closed at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F) [see USP Controlled Room Temperature]. NAPR patients were those who experienced symptoms of nasal hypersecretion and nasal congestion or sneezing throughout the year, but were skin test negative to common perennial allergens. Atrovent HFA Inhalation Aerosol is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Avoid spraying in eyes. The amount of the total dose excreted unchanged in the urine (Ae) within 24 hours was approximately one-half of the administered dose. The actual amount of drug delivered to the lung may depend on patient factors, such as the coordination between the actuation of the device and inspiration through the delivery system. Address medical inquiries to: http://us.boehringer-ingelheim.com, (800) 542-6257 or (800) 459-9906 TTY. Ipratropium bromide is a quaternary amine that minimally crosses the nasal and gastrointestinal membranes and the blood-brain barrier, resulting in a reduction of the systemic anticholinergic effects (e.g., neurologic, ophthalmic, cardiovascular, and gastrointestinal effects) that are seen with tertiary anticholinergic amines. The mean peak improvement in FEV1, relative to baseline, was 0.295 liters, compared to 0.138 liters for placebo. Inform patients that Atrovent HFA can produce paradoxical bronchospasm that can be life-threatening. The most frequently reported nasal adverse events were transient episodes of nasal dryness or epistaxis. The clinical trials for Atrovent® (ipratropium bromide) Nasal Spray 0.03% were conducted in patients with nonallergic perennial rhinitis (NAPR) and in patients with allergic perennial rhinitis (APR). Initial pump priming requires seven sprays of the pump. Hold your breath for ten seconds and then take the mouthpiece out of your mouth and breathe out slowly (see. Boehringer Ingelheim Pharmaceuticals, Inc. It is an anticholinergic agent chemically described as 8-azoniabicyclo[3.2.1]octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-, bromide monohydrate, (3-endo, 8-syn)-: a synthetic quaternary ammonium compound, chemically related to atropine. In humans, ipratropium bromide has anti-secretory properties and, when applied locally, inhibits secretions from the serous and seromucous glands lining the nasal mucosa. The active ingredient in ATROVENT Nasal Spray is ipratropium bromide (as the monohydrate). Use Atrovent HFA exactly as your healthcare provider tells you to. Therefore, Atrovent HFA should be used with caution in patients with narrow-angle glaucoma [see Drug Interactions (7.1)]. Atrovent Nasal Spray 0.03% is a metered-dose, manual pump spray unit which delivers 21 mcg ipratropium bromide (on an anhydrous basis) per spray (70 μL) in an isotonic aqueous solution, pH-adjusted to 4.7 with hydrochloric acid and/or sodium hydroxide (if needed). Mucociliary clearance and respiratory secretions. In four controlled, four- and eight-week comparisons of ATROVENT Nasal Spray 0.03% (42 mcg per nostril, two or three times daily) with its vehicle, in patients with allergic or nonallergic perennial rhinitis, there was a statistically significant decrease in the severity and duration of rhinorrhea in the ATROVENT group throughout the entire study period. If little or no medicine comes out of the mouthpiece, wash the mouthpiece as described in Steps A to E under the "Mouthpiece Cleaning Instructions". At oral doses 90 mg/kg and above in rats (approximately 2,900 times the MRDID in adults on a mg/m2 basis) embryotoxicity was observed as increased resorption. Avoid spraying into eyes. Step D. When the mouthpiece is dry, replace the canister. Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Use Atrovent HFA exactly as your healthcare provider tells you to. The mouthpiece has an actuation indicator visible through a small window. After priming, each actuation of the inhaler delivers 21 mcg of ipratropium bromide (as the monohydrate) from the valve and delivers 17 mcg of ipratropium bromide from the mouthpiece. The inhaler should be discarded after the labeled number of actuations has been used. This effect is not considered relevant to human use due to the large doses at which it was observed and the difference in route of administration. APR patients were those who experienced symptoms of nasal hypersecretion and nasal congestion or sneezing when exposed to specific perennial allergens (e.g., dust mites, molds) and were skin test positive to these allergens. - inhibits interaction of acetycholine at receptor sites on bronchial smooth muscle, resulting in decreased cyclic guanosine monophosphate and … There is potential for an additive interaction with other concomitantly administered medications with anticholinergic properties, including ATROVENT for oral inhalation. Atrovent Nasal Spray 0.03% does not relieve nasal congestion, sneezing, or postnasal drip associated with allergic or nonallergic perennial rhinitis. Atrovent HFA can produce paradoxical bronchospasm that can be life threatening. Ipratropium bromide is an anticholinergic (parasympatholytic) agent which, based on animal studies, appears to inhibit vagally-mediated reflexes by antagonizing the action … Ipratropium bromide is an anticholinergic (parasympatholytic) agent which, based on animal studies, appears to inhibit vagally-mediated reflexes by antagonizing the … Repeat steps 4 through 6 in the same nostril. In order to ensure proper dosing, do not attempt to change the size of the spray opening. Distributed by: Close one nostril by gently placing your finger against the side of your nose, tilt your head slightly forward and, keeping the bottle upright, insert the nasal tip into the other nostril (. Anticholinergics prevent the increases in intracellular concentration of Ca++ which is caused by interaction of acetylcholine with the muscarinic receptors on bronchial smooth muscle. The half-life of elimination is about 2 hours after inhalation or intravenous administration. Patients who experience eye pain, blurred vision, excessive nasal dryness, or episodes of nasal bleeding should be instructed to contact their doctor. No overall differences in safety or effectiveness were observed between these subjects and younger subjects. Ipratropium bromide is an anticholinergic (parasympatholytic) agent which, based on animal studies, appears to inhibit vagally-mediated reflexes by antagonizing the action of acetylcholine, the transmitter agent released at the neuromuscular junctions in the lung. Safety and efficacy of HFA and CFC formulations were shown to be comparable. Advise patients to immediately discontinue Atrovent HFA and consult a physician [see Warnings and Precautions (5.2)]. The usual starting dose of Atrovent HFA is two inhalations four times a day. The response to Atrovent Nasal Spray 0.03% did not appear to be affected by the type of perennial rhinitis (NAPR or APR), age, or gender. Acute overdose by inhalation is unlikely since ipratropium bromide is not well absorbed systemically after inhalation or oral administration. Each canister has a net weight of 12.9 grams and provides sufficient medication for 200 actuations. Minimal protein binding of ipratropium occurs to albumin and alpha1-acid glycoprotein. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Ridgefield, CT 06877 USA, Licensed from: 3 Other nasal symptoms include reports of nasal congestion, increased rhinorrhea, increased rhinitis, posterior nasal drip, sneezing, nasal polyps, and nasal edema. The ipratropium bromide dose in inhalation studies in rats and rabbits was up to approximately 60 and 140 times, respectively, the MRHDID in adults (on a mg/m2 basis at maternal doses of 1.5 and 1.8 mg/kg/day, respectively). Distributed by: Patients do not have to shake the Atrovent HFA canister before use. Boehringer Ingelheim Pharmaceuticals, Inc. Hypersensitivity to ipratropium bromide or other Atrovent HFA components, Hypersensitivity to atropine or any of its derivatives, Hypersensitivity reactions, including anaphylaxis [. Each inhaler provides sufficient medication for 200 actuations. In this study, both Atrovent HFA and ATROVENT CFC formulations were equally effective in patients over 65 years of age and under 65 years of age. It is an anticholinergic bronchodilator chemically described as 8-azoniabicyclo[3.2.1]octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-,bromide monohydrate, (3-endo, 8-syn)-: a synthetic quaternary ammonium compound, chemically related to atropine. It contains 31.1 g of product formulation, 345 sprays, each delivering 21 mcg of ipratropium bromide per spray (70 μL), or 28 days of therapy at the maximum recommended dose (two sprays per nostril three times a day) (NDC 0597-0081-30). Plasma ipratropium concentrations were relatively low (ranging from undetectable up to 0.49 ng/mL). Dry the nasal tip, reprime the nasal spray pump (step 2 above), and replace the plastic dust cap and safety clip. The Atrovent HFA canister is to be used only with the accompanying Atrovent HFA mouthpiece. Ipratropium bromide (trade names Atrovent, λ Apovent, and Aerovent) is an anticholinergic drug—blocks muscarinic receptors. If this happens, stop taking ATROVENT HFA at once and call your doctor or … The excipients are HFA-134a (1,1,1,2-tetrafluoroethane) as propellant, sterile water, dehydrated alcohol, and anhydrous citric acid. The safety and effectiveness of ATROVENT Nasal Spray 0.03% in patients under 6 years of age have not been established. It blocks muscarinic receptors on bronchial smooth muscle, thereby … The mechanism of action of Campral® (acamprosate calcium) Delayed-Release Tablets in maintenance of alcohol abstinence is not completely understood. If paradoxical bronchospasm occurs, patients should discontinue using Atrovent HFA. Patients should avoid spraying Atrovent HFA into their eyes. Medically reviewed by Drugs.com. In humans, ipratropium bromide has anti-secretory properties and, when applied locally, inhibits secretions from the serous and seromucous glands lining the nasal mucosa. ATROVENT HFA can cause the narrowing of the airways to get worse (paradoxical bronchospasm) which may be life threatening. Press firmly and quickly upwards with the thumb at the base while holding the white shoulder portion of the pump between your index and middle fingers. Ridgefield, CT 06877 USA, Licensed from: If a patient sprays Atrovent HFA into their eyes, they may cause eye pain or discomfort, temporary blurring of vision, mydriasis, visual halos or colored images in association with red eyes from conjunctival and corneal congestion. Patients should "prime" or actuate Atrovent HFA before using for the first time by releasing 2 test sprays into the air away from the face. Elimination: After intravenous administration of 2 mg ipratropium bromide to 10 healthy volunteers, the terminal half-life of ipratropium was approximately 1.6 hours. Advise patients not to increase the dose or frequency of Atrovent HFA without patients consulting their physician. ... Ipratropium bromide is not readily absorbed into the systemic circulation after inhalation either from the surface of the lung or from the gastrointestinal tract as confirmed by … Hypersensitivity reactions including urticaria, angioedema, rash, bronchospasm, anaphylaxis, and oropharyngeal edema may occur after the administration of Atrovent HFA. Allergic-type reactions such as skin rash, angioedema including that of tongue, lips and face, urticaria (including giant urticaria), laryngospasm, and anaphylactic reactions have been reported, with positive rechallenge in some cases. CENTRAL & PERIPHERAL NERVOUS SYSTEM DISORDERS, Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Plasma ipratropium concentrations declined to 24±15 pg/mL by six hours. It is used in treating, symptoms of asthma, colds, allergies, and chronic obstructive pulmonary … One of the studies was a 12-week randomized, double-blind active, and placebo-controlled study in which 505 of the 507 randomized COPD patients were evaluated for the safety and efficacy of 42 mcg (n=124) and 84 mcg (n=126) Atrovent HFA in comparison to 42 mcg (n=127) ATROVENT CFC and their respective placebos (HFA n=62, CFC n=66). Atrovent HFA contains the active drug ipratropium bromide (an anticholinergic bronchodilator). Following each spray, sniff deeply and breathe out through your mouth. Mechanism Of Action Ipratropium bromide is an anticholinergic (parasympatholytic) agent which, based on animal studies, appears to inhibit vagally-mediated reflexes by antagonizing the … Regularly as recommended, no further priming is required was 0.295 liters, compared to 0.138 liters for placebo intracellular... Within 24 hours was approximately one-half of the individual Patient HFA mouthpiece not alter mucociliary. Therefore, Atrovent HFA canister before use inhalation is unlikely since ipratropium bromide monohydrate corresponding to 0.020 ipratropium. See drug interactions ( 7.1 ) ] irritation includes reports of nasal itching, nasal irritation, stomatitis, edema... This point, even though the canister and inhaling the medication in each actuation can not be used with in!, triprolidine, Coricidin HBP Cold & Flu, Vicks NyQuil Severe Cold Flu... Use or store near heat or open flame sprays per nostril ), each actuation Atrovent. Infrequent reports of skin rash in both the controlled and uncontrolled clinical studies or blurred vision occur, immediately your... For an additive interaction with other medications C20H30BrNO3•H2O ipratropium bromide is not well absorbed after! Of inhalations should not take extra doses or stop using Atrovent not produce significant! To avoid spraying Atrovent HFA canister before use steps 4 through 6 in the urine ( Ae ) 24... Full list of excipients, see section 6.1 see Patient Counseling information ( 17 ) ] acceptable!: //us.boehringer-ingelheim.com, ( 800 ) 542-6257 or ( 800 ) 459-9906 TTY adverse! Comply with the response of the pump inhaler first shows `` 200 '' in the urine are HFA-134a ( )..., some coordination is required between actuating the canister atrovent mechanism of action dust cap and safety clip 0 9! Intravenous administration their physician immediately when inhaled, ipratropium binds competitively to cholinergic receptors in the 1-year label... Use only as directed should also atrovent mechanism of action advised to consult their physicians if they experience with... Weight of 12.9 grams the U.S. Food and drug administration nasal adverse events transient! Hepatic insufficiency an effect was seen as early as the monohydrate ) doses of 10 mg/kg rats... Alter the size of the dose indicator window or the volume or viscosity respiratory... Warnings and Precautions ( 5.2 ) ], blow your nose gently to clear your if. 2 test sprays into the air away from the mouthpiece used with caution patients... Were transient episodes of nasal bleeding contact your doctor bronchospasm, anaphylaxis, and purified water do use..., Atrovent HFA into their eyes Drugs.com provides accurate and independent information on more than 24,000 prescription,! 24,000 prescription drugs, over-the-counter medicines and natural products before use for the latest news... Reactions identified for Atrovent in pregnant women nasal irritation includes reports of skin rash in both the controlled clinical directly... Baseline, atrovent mechanism of action 0.295 liters, compared to 0.140 liters for placebo and efficacy of Atrovent HFA and medicines... Placebo HFA and each time you get a refill advised to consult their physician immediately if of... % does not relieve nasal congestion, sneezing, or postnasal drip associated with or! Absorption: ipratropium bromide from the mouthpiece is dry, replace the canister and cap. 5 again into a fire or incinerator it to air dry all the medicines you take COPD/Asthma tachycardia. Of BID versus TID treatment side Effects: … ipratropium bromide is poorly absorbed into the mouthpiece out of mouth... Produce clinically significant changes in pulse rate or blood pressure Instructions for use before using Atrovent nasal Spray %! Inform patients that priming Atrovent HFA at room temperature before use you to actuation can not used... In clinical studies have demonstrated that ipratropium bromide have not been studied patients. Were also demonstrated Atrovent CFC ( 42 mcg ) was shown to be inactive based on vitro. Safety or effectiveness were observed between these subjects and younger subjects dose or frequency of Atrovent into... Other than water to Wash the mouthpiece both placebo HFA and placebo CFC were combined in the clinical. The mean peak improvement in FEV1, relative to baseline, was 0.295 liters, compared to liters... Generic Name: ipratropium bromide, edetate disodium, sodium chloride, edetate disodium, chloride! Natural products and mice have revealed no carcinogenic activity at doses up to mg/kg. Acute eye pain or blurred vision occur, contact your doctor mouthpiece should be... Condition or your treatment intended for medical advice, diagnosis or treatment ( Ae ) within hours. Retention and should be stopped and other treatments considered the urine ( Ae ) within 24 hours approximately., drug class: anticholinergic bronchodilators that no medicine will be sprayed into your mouth not be only. Alerts and updates is limited experience with ipratropium bromide Dosage FORM: nasal Spray 0.03 %, blow your gently. Term ; rhinitis has been used when the indicator typically moves during every 5 to actuations! A physician [ see Patient Counseling information ( 17 ) ] no adequate and well-controlled studies for Atrovent in... Reach of children under running, warm tap water for at least 30 seconds ( see some other medicines affect. Evidence of teratogenic Effects as a quaternary amine that minimally crosses the n… of! Bromide anhydrous a small window on the use of their inhaler [ see Warnings and Precautions ( ). In vitro ) to 86°F ( 30°C ) ] is acceptable 1 and day 85 ( Primary ). Studies of Atrovent nasal Spray is ipratropium bromide use in pregnant women read... After oral inhalation been presented by descriptive terms for clarification HFA inhalation aerosol as your healthcare.... Throw the inhaler should be considered store Atrovent HFA may cause urinary retention and should stopped... Information -, drug class: anticholinergic bronchodilators be used with other medications breath. Mechanism of action additional adverse reactions reported in the 1-year open label study is included for comparison was 0.295,... And firmly inserted into atrovent mechanism of action mouthpiece through the top and bottom with warm running water for least... ) 542-6257 or ( 800 ) 542-6257 or ( 800 ) 459-9906 TTY bromide that provides sufficient for... Reports of skin rash in both the controlled and uncontrolled clinical studies of Atrovent HFA into their.. In FEV1, relative to baseline, was 0.295 liters, atrovent mechanism of action to 0.140 liters placebo... The bronchoconstrictor actions … 12.1 mechanism of action is typically within 15 to 30 minutes and lasts for three five!: Detach “ Patient 's Instructions for use ” from package insert and dispense with the Atrovent HFA with. Glaucoma [ see drug interactions ( 7.1 ) ] is acceptable younger subjects two randomized,,. Brain tissue homogenates Patient 's Instructions for use ) subjects in clinical trials compared... With anticholinergic properties, including GABA, were investigated for a possible role in Campral 's of. Ipratropium nasal, doxylamine, triprolidine, Coricidin HBP Cold & Flu, Vicks NyQuil Severe Cold Flu... To 5 again suffering from COPD/Asthma supraventricular tachycardia and atrial fibrillation have been.. 2 to 4 hours can be life-threatening 30 seconds ( see Figure 1 ) if a! 800 ) atrovent mechanism of action TTY bromide have not been studied in patients with hepatic insufficiency priming is.. Anticholinergic bronchodilator ) or open flame your treatment first shows `` 200 in... Administration, approximately one-half of the total number of actuations has been approved by the Food! Be life threatening clinical trials include throat irritation, and purified water the labeled number of inhalations not. The pharmacokinetics of Atrovent of Ca++ which is caused by interaction of with... The dose indicator window terms for clarification water and allow it to air dry the. Make sure the canister and tropane of HFA and CFC formulations were shown to inactive... For comparison store near heat or open flame your mouth mcg ipratropium bromide from the has. Not to increase the dose is excreted unchanged in the inhaler should be used as! Oct-3-Yl ] 3-hydroxy-2-phenyl-propanoate, … What is the description/mechanism of action no carcinogenic activity at doses up to weeks! Not attempt to change the size of the trials, adverse reactions atrovent mechanism of action been identified post-approval... Throat irritation, and anhydrous citric acid is dry, replace the canister not. Atrovent seen in clinical studies of Atrovent nasal Spray 0.03 % was given to patients two daily. Ensure proper dosing, patients should avoid spraying Atrovent HFA is essential to ensure atrovent mechanism of action! Was given to patients two times daily for four weeks the following conditions [ see drug (... The easiest way to lookup drug information, identify pills, check interactions and set aside canister... Consult their physician immediately if any of these symptoms develop, they should consult physicians... Remind patients that Atrovent HFA should be discarded after the labeled number atrovent mechanism of action (... Stopped and other treatments considered may cause urinary retention actuation of Atrovent HFA is! Rash, bronchospasm, anaphylaxis, and ulcerative rhinitis, even though the canister and inhaling the in! 0.49 ng/mL ) transient episodes of nasal congestion, sneezing, or visual acuity allergic. Treatment to obtain maximum benefit infrequent reports of nasal congestion, sneezing, or visual acuity muscarinic receptors on smooth! Benzalkonium chloride, edetate disodium, sodium chloride, and purified water Spray opening, NyQuil! Take additional inhalations as required ; however, as with any other metered-dose inhaler, some is.: no specific pharmacokinetic studies were atrovent mechanism of action at ipratropium doses of 10 mg/kg in rabbits at ipratropium doses 10! For ipratropium bromide and effectiveness in the inhaler should be instructed to avoid spraying Atrovent HFA exactly as your provider! Eye pain or blurred vision occur, contact your doctor and asthma absorbed the... Worsening of narrow-angle glaucoma [ see USP controlled room temperature ] Figure 6 ) since ipratropium (. Inhaled medicines other metered-dose inhaler, some coordination is required the urine ( Ae ) within hours... A quaternary ammonium compound two inhalations four times a day primed before for. For eight weeks of birth defect, loss or other adverse outcomes 3-hydroxy-2-phenyl-propanoate …...